Glutathione deficiency as a prognosis for survival in aids

Details Glutathione deficiency as a prognosis for survival in aids Glutathione deficiency as a prognosis for survival in aids

1996-07-25

1998-12-01

Alexander, Lyle A.

Chemistry: analytical and immunological testing

Peptide, protein or amino acid

436811, G01N 3349

Patent

active

058437851

ABSTRACT:
Glutathione levels are determined using a glutathione surrogate in HIV-positive patients to evaluate survival longevity and determine appropriate treatment. Low glutathione levels indicate a need for a glutathione enhancing supplement and a more aggressive therapeutic regimen, as well as diminishing drugs which may result in the reduction of available glutathione.

REFERENCES:
Biosis 92:447496, Abstract only, 1992.
Biosis 91:461805, Abstract only, 1991.
Biosis 90:90496, Abstract only, 1990.
Staal, F.J.T. et al. "Intracellular Glutathione Deficiency in AIDS: Implications for Therapy," Poster Abstracts, VIII International Conference on AIDS/III STD World Congress, Amsterdam: the Netherlands, Jul. 19-24, 1992 (Abstract No. PoA 2400), p. A69.

Affiliated with

Also associated with

Rating

Glutathione deficiency as a prognosis for survival in aids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glutathione deficiency as a prognosis for survival in aids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutathione deficiency as a prognosis for survival in aids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2395181